Gerhard Fritz

2PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 06, 2024
Combined inhibition of RAD51 and CHK1 causes synergistic toxicity in cisplatin resistant cancer cells by triggering replication fork collapse.

Julia Mann, Kathrin Niedermayer, Johannes Krautstrunk

|Apr 02, 2022
Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression.

Daniela Hanisch, Andrea Krumm, Tamara Diehl

Pageof 1